Immunometabolism of CD8+ T cell differentiation in cancer
Year: 2024
Type: review
Source: Trends in cancer
Authors: Hao Shi, Sidi Chen, Hongbo Chi
Institutions: St. Jude Children's Research Hospital, Yale University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Cancer Research Institute, Alliance for Cancer Gene Therapy, Lupus Research Alliance, American Lebanese Syrian Associated Charities, Pershing Square Sohn Cancer Research Alliance, Servier, National Institutes of Health, KAIST Creative Research Initiatives, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Awards: G1381403927, PILOT DEVELOPMENT OF NEW FORMS OF CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR KIDNEY CANCER., G1980380190, PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY, G3879588058, G431781282, G4597687758, Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance, G5850682332, G6247008096, G6328516692, DEVELOPMENT OF NOVEL IMMUNOTHERAPIES FOR BREAST CANCER, High-throughput in vivo genetics for immunotherapy target discovery, G747555867, G9000017361, G9000065899, G9000213926, G9000305082, Transcriptional and metabolic heterogeneity in T cell differentiation, Advanced development of composite gene delivery and CAR engineering systems, Regulation of T cell memory in tissue immunity, Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
OpenAlex ID: W4396532823